Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
- December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
- 2018 -
2019
-
2020
-
2021
-
2022
-
2023
-
2024
December 2018 - 52 products
L
IP
Ondansetron Accord 8 mg/4 ml
5
67.98
94.55
10 %
Concentrate for infusion: Ondansetronum 8mg / 4ml
Accord Healthcare AG
B / SL / SG
FB
G
IP
CI
Pregabalin Spirig HC 25 mg
14
3.60
8.25
10 %
Capsules: Pregabalinum 25 mg
Spirig HealthCare AG
● 
B / SL / SG
FB
G
IP
CI
Pregabalin Spirig HC 25 mg
56
10.19
19.90
10 %
Capsules: Pregabalinum 25 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 50 mg
14
4.27
9.00
10 %
Capsules: Pregabalinum 50 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 50 mg
84
22.58
42.35
10 %
Capsules: Pregabalinum 50 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 75 mg
14
4.97
9.80
10 %
Capsules: Pregabalinum 75 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 75 mg
56
19.87
39.25
10 %
Capsules: Pregabalinum 75 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 100 mg
84
25.70
45.95
10 %
Capsules: Pregabalinum 100 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 150 mg
56
25.70
45.95
10 %
Capsules: Pregabalinum 150 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 150 mg
168
75.56
103.25
10 %
Capsules: Pregabalinum 150 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 200 mg
84
33.56
55.00
10 %
Capsules: Pregabalinum 200 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 300 mg
56
33.55
54.95
10 %
Capsules: Pregabalinum 300 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pregabalin Spirig HC 300 mg
168
98.67
129.80
10 %
Capsules: Pregabalinum 300 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Baclocalm 10 mg
50
7.21
16.50
10 %
Tablets: Baclofenum 10 mg
Labatec Pharma SA
B / SL / SG
FB
G
IP
CI
Baclocalm 10 mg
200
28.84
49.55
10 %
Tablets: Baclofenum 10 mg
Labatec Pharma SA
B / SL / SG
FB
G
IP
Baclocalm 25 mg
50
14.26
28.70
10 %
Tablets: Baclofenum 25 mg
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
CI
Ezetimib Simvastatin
Zentiva 10/10 mg
28
12.62
26.80
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Ezetimib Simvastatin
Zentiva 10/10 mg
98
44.04
67.00
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Ezetimib Simvastatin
Zentiva 10/20 mg
28
14.22
28.65
10 %
Tablets: 2 Active Agents
Helvepharm AG
● 
B / SL / SG
FB
G
L
IP
Ezetimib Simvastatin
Zentiva 10/20 mg
98
49.63
73.45
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Ezetimib Simvastatin
Zentiva 10/40 mg
28
16.56
35.45
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Ezetimib Simvastatin
Zentiva 10/40 mg
98
57.17
82.10
10 %
Tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Ondansetron Accord 4 mg/2 ml
5
36.48
58.35
10 %
Konzentrat zur Herstellung einer Infusionslösung / Injektionslösung: Ondansetronum 4mg / 2ml
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
CI
Irfen Junior
200 ml
3.98
8.70
10 %
Suspension: Ibuprofenum 100 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Metamizol-Mepha 500 mg
10
5.20
10 %
Tablette: Metamizolum Natricum Monohydricum 500 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Metamizol-Mepha 500 mg
50
2.43
6.90
10 %
Tablette: Metamizolum Natricum Monohydricum 500 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
L
IP
CI
Dacepton 5 mg/ml
5 x 20 ml
173.78
216.10
10 %
Infusion solution: Apomorphini Hydrochloridum Hemihydricum 5 mg/ml
Medius AG
B / SL
FB
G
L
IP
CI
Terrosa
282.53
341.10
10 %
Injection solution: Teriparatidum Adnr 250 µg/ml
Gedeon Richter
(Schweiz) AG
B / SL
FB
G
L
IP
CI
Terrosa
282.53
341.10
10 %
Injection solution: Teriparatidum Adnr 250 µg/ml
Gedeon Richter
(Schweiz) AG
B / SL
FB
G
L
IP
Oncaspar 750 UI/ml
1662.17
1886.30
10 %
Dry substance: Pegaspargasum 3750 UI
Servier (Suisse) SA
A / SL
FB
G
IP
CI
Juluca 50 mg
30
855.65
999.65
10 %
Coated tablets: 2 Active Agents
ViiV Healthcare GmbH
A / SL
FB
G
IP
CI
Saroten 10 mg
50
1.44
5.75
10 %
Coated tablets: Amitriptylinum 10 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
CI
Saroten 10 mg
100
2.45
6.90
10 %
Coated tablets: Amitriptylinum 10 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
Saroten 25 mg
50
3.48
8.10
10 %
Coated tablets: Amitriptylinum 25 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
Saroten 25 mg
100
6.12
15.25
10 %
Coated tablets: Amitriptylinum 25 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
L
IP
CI
Actemra 162 mg/0.9 ml
4
962.96
1118.70
10 %
Injektionslösung in einem Fertigpen zur subkutanen Anwendung: Tocilizumabum 162mg / 0.9ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Dacepton 10 mg/ml
5 x 3 ml
139.55
176.80
10 %
Injektionslösung in einer Patrone: Apomorphini Hydrochloridum Hemihydricum 10 mg/ml
Medius AG
B / SL
FB
G
IP
CI
CM
SUN STORE Pastilles
bronchiques
40
PR
PR
k.A.
6 Active Agents
Sun Store Health Care AG
E
FB
G
IP
SmofKabiven special EF
1012 ml
4 x 1012 ml
PR
PR
k.A.
Infusion emulsion: 16 Active Agents
Infusion emulsion: Glucosum
Infusion emulsion: 4 Active Agents
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
SmofKabiven special EF
1518 ml
4 x 1518 ml
PR
PR
k.A.
Infusion emulsion: 16 Active Agents
Infusion emulsion: Glucosum
Infusion emulsion: 4 Active Agents
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
CI
Terrosa
3
PR
PR
k.A.
Injection solution: Teriparatidum Adnr 250 µg/ml
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
CI
Wakix 4.5 mg
30
PR
PR
k.A.
Coated tablets: Pitolisantum 4.45 mg
Future Health Pharma
GmbH
B
FB
G
IP
Wakix 18 mg
30
PR
PR
k.A.
Coated tablets: Pitolisantum 17.8 mg
Future Health Pharma
GmbH
B
FB
G
IP
CI
Arkocaps Busserole
nouvelle formule
45
PR
PR
k.A.
Capsules: Uvae ursi Folii Pulvis 350 mg
Arko Diffusion AG
D
FB
G
IP
Ezetimib Simvastatin
Zentiva 10/80 mg
28
PR
PR
k.A.
Tablets: 2 Active Agents
Helvepharm AG
B
FB
G
IP
CI
Ornibel
PR
PR
k.A.
Vaginal ring: 2 Active Agents
Exeltis Suisse SA
B
FB
G
IP
CI
Ornibel
3
PR
PR
k.A.
Vaginal ring: 2 Active Agents
Exeltis Suisse SA
B
FB
G
IP
CI
Ornibel
6
PR
PR
k.A.
Vaginal ring: 2 Active Agents
Exeltis Suisse SA
B
FB
G
IP
CI
ellaOne 30 mg
PR
PR
k.A.
Filmtablette: Ulipristalii Acetas 30 mg
HRA-Pharma
Switzerland Sàrl
C
FB
G
IP
CI
Dacepton 10 mg/ml
30 x 3 ml
PR
PR
k.A.
Injektionslösung in einer Patrone: Apomorphini Hydrochloridum Hemihydricum 10 mg/ml
Medius AG
B
FB
G
IP
CI
Irfen Dolo Junior 100 mg / 5 ml
200 ml
PR
PR
k.A.
Suspension: Ibuprofenum 100 mg
Mepha Pharma AG
D
FB
G
IP
CI
Alofisel
4
PR
PR
k.A.
x: Darvadstrocelum 30x10e6Zellen (Easc) In 6 ml
Takeda Pharma AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home